Skip to main content
SpringerLink
Log in

Diabetes Mellitus

  • Reference work entry
  • First Online:
Family Medicine

  • 250 Accesses

Abstract

Diabetes mellitus is a group of diseases characterized by hyperglycemia and other metabolic abnormalities resulting from impaired insulin secretion and/or its action at the cellular level.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 899.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 999.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. https://www.diabetes.org/resources/statistics/statistics-about-diabetes. 20 Apr 2020.

  2. https://www.cdc.gov/diabetes/data/statistics/statistics-report.html. 20 Apr 2020.

  3. American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14–31. https://doi.org/10.2337/dc20-S002.

    Article  Google Scholar 

  4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.

    Article  Google Scholar 

  5. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the diabetes control and complications trial cohort. Diabetes Care. 1999;22(1):99–111.

    Article  Google Scholar 

  6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.

    Article  Google Scholar 

  7. Pharmacologic Approaches to Glycemic Treatments. Standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S98–S110.

    Google Scholar 

  8. Melmed S, Polonsky K, Larsen PR, Kronenberg H. Williams textbook of endocrinology. 12th ed. Philadelphia: Elsevier Saunders; 2011.

    Google Scholar 

  9. American Diabetes Association. Diabetes technology: standards of medical Care in Diabetes – 2020. Diabetes Care. 2020;43(Suppl 1):S77–88. https://doi.org/10.2337/dc20-S007.

    Article  Google Scholar 

  10. American Diabetes Association. Tests of glycemia in diabetes. Diabetes Care. 2004;27(Suppl 1):s91–3. https://doi.org/10.2337/diacare.27.2007.S91.

    Article  Google Scholar 

  11. American Diabetes Association. Standards of medical care in diabetes-2020 abridged for primary care providers. Clinical Diabetes. 2020;38(1):10–38.

    Article  Google Scholar 

  12. American Diabetes Association. Management of Diabetes in pregnancy: standards of medical Care in Diabetes – 2019. Diabetes Care. 2019;42(Suppl 1):S165–72.

    Article  Google Scholar 

  13. American Diabetes Association. Lifestyle management: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S46–60.

    Article  Google Scholar 

  14. American Diabetes Association. Cardiovascular disease and risk management: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S103–23.

    Article  Google Scholar 

  15. Kernan W, Viscoli CM, Furie K, Young L, Inzucchi S, Gorman M. Pioglitazone after ischemic stroke or transient ischemic attack. N Engl J Med. 2016;374:1321–31.

    Article  CAS  Google Scholar 

  16. Marso S, Daniels G, Brown-Frandsen K, Kristensen P, Mann J, Nauck M, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375:311–22.

    Article  CAS  Google Scholar 

  17. Marso S, Bain S, Consoli A, Eliaschewitz F, Jodar E, Leiter L, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375:1834–44.

    Article  CAS  Google Scholar 

  18. Gesrtein H, Colhoun H, Dagenais G, Diaz R, Lakshmanan M, Pais P, et al. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double blind, randomized placebo-controlled trial. Lancet. 2019;394:121–30.

    Article  Google Scholar 

  19. Mann J, Orsted D, Brown-Frandsen K, Steven M, Poulter N, Rasmussen S, et al. Liraglutide and renal outcomes in type 2 diabetes. N Engl J Med. 2017;377:839–48.

    Article  CAS  Google Scholar 

  20. Zinman B, Wanner C, Lachin J, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, cardiovascular outcomes and mortality in type 2 diabetes. N Engl J Med. 2015;373:2117–28.

    Article  CAS  Google Scholar 

  21. Mcmurray J, Solomon S, Inzucchi S, Kober L, Kosiborod M, Martinez F, et al. Dapgliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381:1995–2008.

    Article  CAS  Google Scholar 

  22. Perkovic V, Jardine M, Neal B, Bompoint S, Heerspink H, Charytan DM, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med. 2019;380:2295–306.

    Article  CAS  Google Scholar 

  23. American Diabetes Association. Glycemic targets: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S66–76.

    Article  Google Scholar 

  24. Beigi I, et al. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med. 2011;154:554–9.

    Article  Google Scholar 

  25. American Diabetes Association. Microvascular complications and foot care: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S135–51.

    Article  Google Scholar 

  26. Bhatt D, Steg G, Miller M, Brinton E, Jacobson T, Ketchum S. Cardiovascular risk reduction with Icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019;380:11–22.

    Article  CAS  Google Scholar 

  27. Kitabchi A, Umpierrez G, Miles J, Fisher J. Hyperglycemic crisis in adult patients with diabetes. Diabetes Care. 2009;32(7):1335–43.

    Article  CAS  Google Scholar 

  28. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes 2020. Diabetes care 2020. Diabetes Care. 2020;43(Suppl 1):S193–202.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical and Molecular Endocrinology, University Hospitals-Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA

    Nadine El Asmar & Baha M. Arafah

  2. University Hospitals-Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA

    Charles Kent Smith

Authors
  1. Nadine El Asmar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Baha M. Arafah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charles Kent Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nadine El Asmar .

Editor information

Editors and Affiliations

  1. Department of Family Medicine, University of Nebraska Medical Center, Omaha, NE, USA

    Paul M. Paulman

  2. Department of Family and Community Medicine, Eastern Virginia Medical School, Norfolk, VA, USA

    Robert B. Taylor

  3. Department of Family Medicine, University of Nebraska Medical Center, Omaha, NE, USA

    Audrey A. Paulman

  4. Department of Family Medicine, Creighton University School of Medicine, Omaha, NE, USA

    Laeth S. Nasir

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

El Asmar, N., Arafah, B.M., Smith, C.K. (2022). Diabetes Mellitus. In: Paulman, P.M., Taylor, R.B., Paulman, A.A., Nasir, L.S. (eds) Family Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-54441-6_186

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-54441-6_186

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-54440-9

  • Online ISBN: 978-3-030-54441-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation